GLI1 and cancer: GLI1 protein levels were also reduced in a dose-dependent manner upon treatment with IBET-151 (Supplementary Figure 4D and 4E), and this observation is consistent with previous studies showing IBET-151 attenuating the activity of a number of genes important to the proliferation and survival of cancer cells, including GLI1 [18].